1240518-02-8

Basic information

• Product Name: 3-[(3-amino-4-methoxy-1H-indazol-1-yl)methyl]benzonitrile
• Synonyms: 3-[(3-amino-4-methoxy-1H-indazol-1-yl)methyl]benzonitrile
• CAS NO: 1240518-02-8
• Molecular Weight: 278.313
• Mol File: 1240518-02-8.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: 3-[(3-amino-4-methoxy-1H-indazol-1-yl)methyl]benzonitrile(CAS DataBase Reference)
• NIST Chemistry Reference: 3-[(3-amino-4-methoxy-1H-indazol-1-yl)methyl]benzonitrile(1240518-02-8)
• EPA Substance Registry System: 3-[(3-amino-4-methoxy-1H-indazol-1-yl)methyl]benzonitrile(1240518-02-8)

Safety Data

• Hazardous Substances Data: 1240518-02-8(Hazardous Substances Data)

Upstream product

• 94088-46-7 2-fluoro-6-methoxybenzonitrile 
• 886362-07-8 4-(methyloxy)-1H-indazol-3-amine 
• 64407-07-4 3-(chloromethyl)benzonitrile 

Downstream Products

• 1240518-03-9 5-chloro-N-{1-[(3-cyanophenyl)methyl]-4-(methoxy)-1H-indazole-3-yl}-2-thiophene sulphonamide 
• 1240518-04-0 N-[1-{[3-(aminomethyl)phenyl]methyl}-4-methyloxy-1H-indazol-3-yl]-5-chloro-2-thiophenesulfonamide hydrochloride 
• 1361109-96-7 methyl 4-((3-((3-(5-chlorothiopene-2-sulfanamido)-4-methoxy-1H-indazol-1-yl)methyl)benzyl)carbamoyl)benzoate 
• 1361330-38-2 2,3-dichloro-N-[1-[(3-cyanophenyl)methyl]-4-(methyloxy)-1H-indazol-3-yl]benzenesulfonamide 
• 1361330-34-8 N-[1-[(3-cyanophenyl)methyl]-4-(methyloxy)-1H-indazol-3-yl]-3-fluoro-4-methylbenzenesulfonamide 
• 1240518-30-2 N-[(3-{[3-amino-4-(methyloxy)-1H-indazol-1-yl]methyl}phenyl)methyl]acetamide 
• 1361330-33-7 1,1-dimethylethyl (3R)-3-({[(3-{[3-amino-4-(methyloxy)-1H-indazol-1-yl]methyl}phenyl)methyl]amino}carbonyl)-4-morpholinecarboxylate 
• 1361330-27-9 N-[(3-{[3-{[(2,3-dichlorophenyl)sulfonyl]amino}-4-(methyloxy)-1H-indazol-1-yl]methyl}phenyl)methyl]-2-hydroxy-2-methylpropanamide 
• 1361330-28-0 N-[(3-{[3-{[(3-chlorophenyl)sulfonyl]amino}-4-(methyloxy)-1H-indazol-1-yl]methyl}phenyl)methyl]-2-hydroxy-2-methylpropanamide 
• 1361330-29-1 N-[(3-{[3-{[(3,4-dichlorophenyl)sulfonyl]amino}-4-(methyloxy)-1H-indazol-1-yl]methyl}phenyl)methyl]-2-hydroxy-2-methylpropanamide 
• 1361330-30-4 N₁-[(3-{[3-{[(3-chlorophenyl)sulfonyl]amino}-4-(methyloxy)-1H-indazol-1-yl]methyl}phenyl)methyl]-2-methylalaninamide 
• 1361330-53-1 2-{[(3-{[3-{[(3-fluoro-4-methylphenyl)sulfonyl]amino}-4-(methyloxy)-1H-indazol-1-yl]methyl}phenyl)methyl]amino}-1,1-dimethyl-2-oxoethyl acetate 
• 1361330-54-2 C₃₃H₃₈FN₅O₇S 
• 1361330-59-7 C₂₈H₂₈Cl₂N₄O₆S 

Relevant articles and documents

COMPOUND, PREPARATION METHOD THEREFOR, AND USE THEREOF

The present disclosure provides a compound of formula I or a pharmaceutically acceptable salt, a solvate, or a prodrug thereof, wherein M is a monovalent alkali metal. The present disclosure also provides a method for preparing the compound or its pharmaceutically acceptable salt, solvate, or prodrug, and further provides a pharmaceutical composition containing the compound and its use in the preparation of a medicine, which can be used for the treatment of CCR4-mediated diseases.

INDAZOLE COMPOUNDS

Indazole compounds, processes for their preparation, pharmaceutical compositions containing such compounds and their use in therapy.

NOVEL COMPOUNDS

Indazole compounds, processes for their preparation, intermediates usable in these processes, pharmaceutical compositions containing such compounds and their use in therapy.